Search Result "Core-Binding Factor AML"
Developments of Fms-like Tyrosine Kinase 3 Inhibitors as AnticancerAgents for AML Treatment
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 29 Year: 2024 Page: 4657-4686
Author(s):
Protein Kinase Inhibitors as Therapeutic Drugs in AML: Advances and Challenges
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 29 Year: 2017 Page: 4303-4310
Author(s): Yuan Ling,Zikang Zhang,Hua Zhang,Zunnan Huang
Nontoxic-dose of Deguelin Induce NPMc+ AML Cell Differentiation by Selectively Targeting Mt NPM1/SIRT1 Instead of HDAC1/3
Journal: Current Cancer Drug Targets
Volume: 14 Issue: 8 Year: 2014 Page: 685-699
Author(s): You P. Wang,Sha Yi,Lu Wen,Ben P. Zhang,Zichu Zhao,Jing Y. Hu,Fei Zhao,Jing He,Jun Fang,Chun Zhang,Guohui Cui,Yan Chen
The Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway as a Therapeutic Target for the Treatment of Human Acute Myeloid Leukemia (AML)
Journal: Current Signal Transduction Therapy
Volume: 2 Issue: 3 Year: 2007 Page: 246-256
Author(s): Alberto M. Martelli, Giovanna Tabellini, Roberta Bortul, Maria Nyakern, Pier Luigi Tazzari, Camilla Evangelisti, Lucio Cocco
Molecular Markers of Regulatory T Cells in Cancer Immunotherapy with Special Focus on Acute Myeloid Leukemia (AML) - A Systematic Review
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 28 Year: 2020 Page: 4673-4698
Author(s): Parham Jabbarzadeh Kaboli,Lingling Zhang,Shixin Xiang,Jing Shen,Mingxing Li,Yueshui Zhao,Xu Wu,Qijie Zhao,Hanyu Zhang,Ling Lin,Jianhua Yin,Yuanlin Wu,Lin Wan,Tao Yi,Xiang Li,Chi Hin Cho,Jing Li,Zhangang Xiao,Qinglian Wen
Oncogenic Signaling in Acute Myeloid Leukemia
Journal: Current Drug Targets
Volume: 8 Issue: 2 Year: 2007 Page: 237-246
Author(s): Christian H. Brandts, Wolfgang E. Berdel, Hubert Serve
An Overview on G Protein-coupled Receptor-induced Signal Transduction in Acute Myeloid Leukemia
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 28 Year: 2019 Page: 5293-5316
Author(s): Frode Selheim,Elise Aasebø,Catalina Ribas,Anna M. Aragay
Implications of Somatic Mutations in the AML1/RUNX1 Gene in Myelodysplastic Syndrome (MDS): Future Molecular Therapeutic Directions for MDS
Journal: Current Cancer Drug Targets
Volume: 6 Issue: 6 Year: 2006 Page: 553-563
Author(s): Hironori Harada, Yuka Harada, Akiro Kimura
Targeting Transcription Factors in Acute Leukemia in Children
Journal: Current Drug Targets
Volume: 8 Issue: 6 Year: 2007 Page: 727-737
Author(s): Jason N. Berman, A. Thomas Look
Novel and Emerging Drugs for Acute Myeloid Leukemia: Pharmacology and Therapeutic Activity
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 5 Year: 2011 Page: 638-666
Author(s): T. Robak, A. Szmigielska-Kaplon, A. Pluta, O. Grzybowska-Izydorczyk, A. Wolska, M. Czemerska, A Wierzbowska